<?xml version="1.0" encoding="UTF-8" ?>
	<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	  <channel>
	  <copyright>Copyright 2009 Medical News Today</copyright>
	  <description>Latest Bones / Orthopaedics News From Medical News Today.</description>
	  <link>http://www.medicalnewstoday.com/sections/bones/</link>
	  <title>Bones / Orthopaedics News From Medical News Today</title>
	  <webMaster>admin&#064;medicalnewstoday.com  (MNT Admin)</webMaster>
	  <managingEditor>editors&#064;medicalnewstoday.com  (MNT Editors)</managingEditor>
	  <language>en-us</language><atom:link href="http://www.medicalnewstoday.com/rss/bones-bone_disorders.xml" rel="self" type="application/rss+xml" /><item><title>$11 Million NIH Grant For Stem Cell Research Awarded To Rhode Island Hospital</title><pubDate>Sat, 07 Nov 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170162.php</link><guid>http://www.medicalnewstoday.com/articles/170162.php</guid><description>Rhode Island Hospital has received an $11 million grant to fund research that will lead to a general understanding of stem cell biology and identify unique approaches to tissue regeneration in lung and marrow diseases. The 5&#45;year grant, awarded to Peter Quesenberry, MD, director of hematology/oncology at Rhode Island Hospital, also provides funding for the development of a major stem cell research center at Rhode Island Hospital.</description><category domain="http://www.medicalnewstoday.com/sections/stem_cell/">Stem Cell Research</category></item><item><title>Approved Lymphoma Drug Shows Promise In Early Tests Against Bone Cancer</title><pubDate>Fri, 06 Nov 2009 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170040.php</link><guid>http://www.medicalnewstoday.com/articles/170040.php</guid><description>A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early&#45;stage study published online in the International Journal of Cancer. The study drug, Bortezomib, was found to be effective against bone cancer in human cancer cell studies and in mice.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Custom Spine Receives 510k Clearance Of Regent ACP</title><pubDate>Fri, 06 Nov 2009 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170045.php</link><guid>http://www.medicalnewstoday.com/articles/170045.php</guid><description>Regent ACP, Custom Spine's anterior cervical plate system, has received 510k Clearance from the U.S. Food and Drug Administration (FDA). This product clearance marks the latest addition to Custom Spine's continually expanding product line.    Regent ACP is a low profile anterior cervical plate system that was designed with innovative self&#45;locking slides to give the surgeon confidence of the plate being securely locked into place.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>American Association Of Orthopaedic Surgeons, Nineteen Other Surgical Groups Call For Changes To Senate Health Legislation</title><pubDate>Fri, 06 Nov 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170034.php</link><guid>http://www.medicalnewstoday.com/articles/170034.php</guid><description>The American Association of Orthopaedic Surgeons (AAOS) joined nineteen other surgical organizations, led by the American College of Surgeons, to send a letter to the U.S. Senate today reiterating they are prepared to oppose the Senate's health care reform bill due to its threat to patients' access to specialty care and its potential to harm quality care. This coalition represents over 240,000 surgeons and anesthesiologists.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>First&#45;Ever Leading Calcium Supplement To Help Support Bone and Heart Health</title><pubDate>Fri, 06 Nov 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170010.php</link><guid>http://www.medicalnewstoday.com/articles/170010.php</guid><description>Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis&#45;related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>New Lung Health Research Presented At CHEST 2009</title><pubDate>Thu, 05 Nov 2009 04:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169946.php</link><guid>http://www.medicalnewstoday.com/articles/169946.php</guid><description>Osteoporosis Linked to Bronchiectasis  (#8660)    Patients with non&#45;cystic fibrosis bronchiectasis may have a high incidence of osteopenia and osteoporosis. Researchers from Scott &#38; White Hospital and Texas A&#38;M Health Science Center College of Medicine in Texas reviewed the records of 113 patients admitted to the hospital with acute exacerbation of bronchiectasis. The mean age of the patients was 63 years, 76 percent were Caucasian, and 70 percent were women.</description><category domain="http://www.medicalnewstoday.com/sections/asthma-respiratory/">Respiratory / Asthma</category></item><item><title>BioMimetic Therapeutics Receives First Orthopedic Marketing Approval For Augment&#x2122; Bone Graft</title><pubDate>Wed, 04 Nov 2009 16:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169844.php</link><guid>http://www.medicalnewstoday.com/articles/169844.php</guid><description>BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that it has received approval from Health Canada to begin the marketing of its lead orthopedic product, Augment&#x2122; Bone Graft, as an alternative to the use of autograft in midfoot, hindfoot and ankle fusion indications in Canada.   "After rigorous pre&#45;clinical and clinical evaluation of the product, BioMimetic is now ready to introduce this novel, implantable biologic to the marketplace," commented Dr. Samuel E.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Enobia Expands Clinical Program For ENB&#45;0040, A Bone&#45;Targeted Enzyme Replacement Therapy For Hypophosphatasia</title><pubDate>Wed, 04 Nov 2009 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169745.php</link><guid>http://www.medicalnewstoday.com/articles/169745.php</guid><description>Enobia Pharma announced the initiation of a Phase 2 clinical study of ENB&#45;0040, a bone&#45;targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six&#45;month study will assess the safety, efficacy and pharmacokinetics of ENB&#45;0040 in up to 12 children with HPP.</description><category domain="http://www.medicalnewstoday.com/sections/endocrinology/">Endocrinology</category></item><item><title>Improved Healing Of Bone Fractures After Radiation Exposure</title><pubDate>Tue, 03 Nov 2009 06:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169677.php</link><guid>http://www.medicalnewstoday.com/articles/169677.php</guid><description>A drug currently under development by the University of Pittsburgh School of Medicine may help bone fractures heal more quickly after radiation exposure, according to a study by Pitt researchers. The study's results were presented during the American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.    The drug, JP4&#45;039, is a free&#45;radical scavenger targeted to the mitochondria, the energy generator of all cells.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Aggressive Osteoporosis Prevention Could See Nation's Hip Fracture Rate Drop 25 Percent</title><pubDate>Tue, 03 Nov 2009 03:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169584.php</link><guid>http://www.medicalnewstoday.com/articles/169584.php</guid><description>Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone &#38; Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>NHS Institute Launches Focus On: Musculoskeletal Interface Services</title><pubDate>Tue, 03 Nov 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169516.php</link><guid>http://www.medicalnewstoday.com/articles/169516.php</guid><description>The NHS Institute for Innovation and Improvement has launched a new publication to support the NHS in improving community&#45;based access to specialist services for patients suffering from musculoskeletal (MSK) conditions such as chronic back pain, osteoporosis and other bone, joint, spinal and muscular diseases.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Shock&#45;Wave Therapy For Unhealed Fractured Bones As Effective As Surgery</title><pubDate>Tue, 03 Nov 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169536.php</link><guid>http://www.medicalnewstoday.com/articles/169536.php</guid><description>When fractured bones fail to heal, a serious complication referred to as "nonunion" can develop. This occurs when the process of bone healing is interrupted or stalled. According to a new study published in the November 2009 issue of The Journal of Bone and Joint Surgery (JBJS),  certain cases involving nonunions respond very well to shock&#45;wave therapy.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Mending Meniscals In Children, Improving Diagnosis And Recovery</title><pubDate>Tue, 03 Nov 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169537.php</link><guid>http://www.medicalnewstoday.com/articles/169537.php</guid><description>The meniscus is a rubber&#45;like, crescent moon&#45;shaped cartilage cushion that sits between the leg and thigh bone. Each knee has two menisci: one on the inside of the knee joint and one on the outside. In recent years, more children have been diagnosed with tears to this area (meniscal tears); however, according to a literature review published in the November 2009 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS),  prospects for a full recovery are high.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>USANA Supported Clinical Study Demonstrates Improved Bone Health In Girls</title><pubDate>Mon, 02 Nov 2009 04:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169491.php</link><guid>http://www.medicalnewstoday.com/articles/169491.php</guid><description>USANA Health Sciences, Inc. (NASDAQ: USNA) announced that a third&#45;party clinical study led by Dr. David Greene at Australian Catholic University (ACU National) found that use of USANA's Active Calcium&#x2122; Chewable supplement improves bone health in young girls.   The double&#45;blind, placebo&#45;controlled study involved 20 pairs of identical twin girls, ages 9&#45;12 years old, who were randomly assigned to receive USANA's Active Calcium Chewable or a matching placebo.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Teriparatide Outperforms Alendronate In Treating Steroid&#45;Induced Osteoporosis</title><pubDate>Fri, 30 Oct 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169190.php</link><guid>http://www.medicalnewstoday.com/articles/169190.php</guid><description>A recent study determined glucocorticoid&#45;induced osteoporosis (OP) is now treatable with Teriparatide, a synthetic form of the human parathyroid hormone. Researchers found patients with glucocorticoid&#45;induced OP who were treated with teriparatide for 36 months had a greater increase in bone mineral density (BMD) and fewer new vertebral fractures than those treated with alendronate.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Geisinger Orthopaedic Surgeon Awarded $97,000 Grant</title><pubDate>Fri, 30 Oct 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169206.php</link><guid>http://www.medicalnewstoday.com/articles/169206.php</guid><description>A Geisinger orthopaedic surgeon recently received a $97,000 grant from the Orthopaedic Trauma Association for a pilot study that will expand Geisinger's ProvenHealth Navigator advanced medical home to include care for patients recovering from hip fractures.     Wade Smith, M.D.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>ThromboGenics And BioInvent Complete Patient Recruitment Of Phase II DVT Prophylaxis Study With Anti&#45;Factor VIII (TB&#45;402)</title><pubDate>Thu, 29 Oct 2009 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169088.php</link><guid>http://www.medicalnewstoday.com/articles/169088.php</guid><description>ThromboGenics NV (Euronext Brussels: THR) and co&#45;development partner BioInvent International (OMXS: BINV) announce that they have completed recruitment of their Phase II trial of TB&#45;402 ahead of schedule. TB&#45;402 is a novel, long acting anticoagulant that is being developed for the prevention of deep vein thrombosis (DVT) following orthopaedic surgery. The results of this study, which has recruited 315 patients, are anticipated in the second quarter of 2010.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Consortia Of European Scientists Show New Role For Master Patterning Genes In Defining Number Of Vertebrae In Spine</title><pubDate>Wed, 28 Oct 2009 06:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169023.php</link><guid>http://www.medicalnewstoday.com/articles/169023.php</guid><description>Vertebrates have in common a skeleton made of segments, the vertebrae. During development of the embryo, each segment is added in a time dependent manner, from the head&#45;end to the tail&#45;end: the first segments to be added become the vertebrae of the neck, later segments become the vertebrae with ribs and the last ones the vertebra located in the tail (in the case of a mouse, for example).</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Tiny Sea Creature And A New Medical Adhesive: New American Chemical Society Podcast</title><pubDate>Wed, 28 Oct 2009 05:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169006.php</link><guid>http://www.medicalnewstoday.com/articles/169006.php</guid><description>Scientists questing after a long&#45;sought new medical adhesive describe copying the natural glue secreted by a tiny sea creature called the sandcastle worm in the latest episode in the American Chemical Society's (ACS) award&#45;winning podcast series, "Global Challenges/Chemistry Solutions."    Such an adhesive is needed to repair bones shattered in battlefield injuries, car crashes and other accidents.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Invitation To Attend The World Congress On Osteoporosis 2010 (IOF WCO &#45; ECCEO10)</title><pubDate>Wed, 28 Oct 2009 04:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/168981.php</link><guid>http://www.medicalnewstoday.com/articles/168981.php</guid><description>Springtime in Tuscany! Come to Florence to hear the world's key opinion leaders in osteoporosis talk about the field's 'hot topics' and join in clinically&#45;oriented 'Meet&#45;the&#45;Expert' sessions, limited in size for maximum interaction between experts and participants.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>In Medical First, Packard Children's Orthopedic Surgeon Implants High&#45;Tech Artificial Bone In Three&#45;Year&#45;Old's Arm</title><pubDate>Tue, 27 Oct 2009 22:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/168868.php</link><guid>http://www.medicalnewstoday.com/articles/168868.php</guid><description>When little Mark Blinder was diagnosed with a rare bone cancer, doctors at Lucile Packard Children's Hospital gave his parents three agonizing options: amputate the affected arm at the shoulder, irradiate the tumor and risk a second malignancy, or try a limb&#45;preserving surgery that had never been attempted in a toddler.   Nearly a year later, Mark, now four, is thriving with a surgically implanted artificial humerus inside his cancer&#45;free right arm.</description><category domain="http://www.medicalnewstoday.com/sections/cancer-oncology/">Cancer / Oncology</category></item><item><title>Aluminum Exposure From Intravenous Feeding Solutions May Be Associated With Future Bone Loss</title><pubDate>Tue, 27 Oct 2009 17:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/168859.php</link><guid>http://www.medicalnewstoday.com/articles/168859.php</guid><description>Humans are exposed to aluminum from a variety of sources, including drinking water, infant formula, breast milk and some medications. Preterm infants who receive intravenous feeding solutions with aluminum, often to ensure their survival, may have reduced lumbar spine and hip bone mass in adolescence. In addition, these children also may face a potential risk of osteoporosis and hip fractures as adults.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Discovery Of Thoracic Spine Abnormality Resolves Undiagnosed Pain Primarily In Younger Women</title><pubDate>Tue, 27 Oct 2009 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/168774.php</link><guid>http://www.medicalnewstoday.com/articles/168774.php</guid><description>The discovery of a multi&#45;level arteriovenous malformation (AVM) in the thoracic epidural space can now bring relief to potentially thousands of suffers of chronic thoracic pain and progressive myelopothy. Identified as thoracic epidural arteriovenous malformation (T.E.A.M.), this particular AMV primarily affects younger women ages 20 to 40.</description><category domain="http://www.medicalnewstoday.com/sections/back-pain/">Back Pain</category></item><item><title>New Study Suggests Millions Of American Kids May Not Have Enough Vitamin D, Especially Non&#45;Whites</title><pubDate>Mon, 26 Oct 2009 10:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/168733.php</link><guid>http://www.medicalnewstoday.com/articles/168733.php</guid><description>A new nationally representative study suggests that millions of children in the US between the ages of 1 and 11 don't have enough vitamin D, and     that non&#45;whites, such as black and Hispanic children are especially at risk.</description><category domain="http://www.medicalnewstoday.com/sections/pediatrics/">Pediatrics / Children's Health</category></item><item><title>What Are Flat Feet (pes Planus, Fallen Arches)? What Causes Flat Feet?</title><pubDate>Sun, 25 Oct 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/168608.php</link><guid>http://www.medicalnewstoday.com/articles/168608.php</guid><description>Most people have a gap under the arch of their foot when they are in a standing position. The arch, the inner part of the foot is slightly raised off the ground. People with flat feet or fallen arches either have no arch, or it is very low.     The feet of people with flat feet may roll over to the inner side when they are standing or walking, and the feet may point outwards as a result.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item></channel></rss>